Skin biopsy billing starts with the purpose and technique documented for each lesion. Sending tissue to pathology does not, by itself, determine whether the service is a biopsy, shave removal, or excision.
CPT codes 11102–11107 distinguish tangential, punch, and incisional skin biopsies. Accurate claims also depend on lesion count, anatomical site, diagnosis support, and the relationship to other services performed during the encounter.
Skin Biopsy CPT Codes by Technique
A skin biopsy obtains tissue for diagnostic evaluation. The procedure note needs to describe how the sample was obtained; “biopsy performed” alone is insufficient to distinguish these techniques.
Surface-Oriented Sampling
Techniques may include shave, scoop, saucerization, or curettage. Document the diagnostic purpose and technique.
Punch-Instrument Sampling
A punch instrument obtains a cylindrical sample. Document the technique and tissue depth needed to support the code.
Sampling Through an Incision
An incision removes a portion of the lesion for diagnosis. Document the procedure rather than inferring it from the specimen.
Primary and Additional-Lesion Codes
| Technique | Primary Code | Each Additional Lesion |
|---|---|---|
| Tangential biopsy | 11102 | +11103 |
| Punch biopsy | 11104 | +11105 |
| Incisional biopsy | 11106 | +11107 |
Count lesions, not containers. Multiple tissue fragments, passes, or pathology containers from one lesion do not automatically establish additional reportable biopsies. The “+” marks an add-on code; it is not part of the five-digit claim code.
Add-on codes cannot be reported alone. For mixed techniques, use the primary/add-on reporting rules below, rather than a separate primary code for each technique.
How to Code Multiple Skin Biopsies
Document each separately biopsied lesion and its technique. Report one primary skin biopsy code for the encounter, with the applicable technique-specific add-on codes for the remaining lesions.
Use the applicable CPT hierarchy, not a comparison of payer reimbursement amounts. Confirm permitted primary/add-on combinations in the current CPT reference.
Three Tangential Biopsies
Three separately documented lesions are sampled using the tangential technique.
11102 × 1
11103 × 2
The first lesion uses the primary code; the other two use additional-lesion units. Follow payer instructions for claim-line formatting.
One Incisional, One Punch, One Tangential
Three separate lesions are biopsied during the same encounter.
11106 × 1
11105 × 1
11103 × 1
Incisional is primary. The punch and tangential biopsies use their corresponding add-on codes.
For example, map lesion A on the upper back to the incisional biopsy, lesion B on the forearm to the punch biopsy, and lesion C on the cheek to the tangential biopsy. That mapping supports the claim more clearly than “three lesions biopsied.”
Skin Biopsy Versus Shave Removal
Similar instruments can be used for different procedures. The documented purpose and work performed determine the appropriate code family.
Tangential Biopsy
Tissue is sampled to establish a diagnosis. Codes 11102 and +11103 may apply when the technique and reporting requirements are met.
Document: the lesion, clinical concern, technique, and diagnostic intent.
Shave Removal
The primary purpose is removal of the lesion. Code selection depends on the documented removal procedure, anatomical site, and lesion size.
Document: the removal intent, site, and dimensions relevant to code selection.
Pathology does not create a second procedure. A biopsy should not be separately added to shave removal of the same lesion simply because the removed tissue is submitted for examination. Review the CMS lesion-removal guidance.
When Site-Specific Biopsy Codes Apply
The general skin biopsy family does not cover every anatomical structure. Check whether a more specific biopsy code describes the documented site and procedure.
Examples Requiring Site-Specific Review
| Site or Structure | Code to Review |
|---|---|
| Nail unit | 11755 |
| Lip | 40490 |
| External ear | 69100 |
| Eyelid skin, including lid margin | 67810 |
| Penis | 54100 |
| Vulva/perineum | 56605; +56606 for additional lesions when applicable |
These are reference examples, not automatic code assignments. Confirm the exact descriptor, anatomical structure sampled, technique requirements, and payer rules before selecting a code.
Modifiers Used With Skin Biopsy Claims
Modifier selection depends on the relationship between services. An additional diagnosis, another claim line, or new-patient status alone does not establish separately reportable work.
Modifier 25: Separate E/M Work
Modifier 25 belongs on the E/M service when significant, separately identifiable work exceeds the usual work associated with the biopsy. The E/M and biopsy can share a diagnosis.
Additional Evaluation and Management
The clinician evaluates an inflammatory skin condition, manages medication, and establishes follow-up, while also biopsying a suspicious lesion. Documentation must support the additional E/M work and selected level.
Routine Biopsy Assessment
The visit consists of assessing a lesion, deciding to biopsy, obtaining consent, and performing the procedure. Routine procedure-related work does not automatically support a separate E/M charge.
For additional examples, review the modifier 25 dermatology billing guidelines.
Modifier 59 and X Modifiers: Distinct Procedures
Use these modifiers only when the specific edit permits an override and the documented circumstances support distinct services. Choose a more specific modifier when it better describes the relationship and meets payer requirements.
Biopsy on Shoulder; Cryotherapy on Forehead
Identify the biopsied lesion and the separately treated lesions. Clear mapping may support a distinct-service modifier when the applicable edit permits it.
Biopsy Followed by Treatment
Do not add modifier 59 merely to obtain separate payment for bundled work directed at the same lesion. Separate diagnosis codes do not resolve the procedural overlap.
CMS specifically discusses primary biopsy codes 11102, 11104, and 11106 paired with destruction codes 17000 and 17004. Read the 2026 NCCI policy, Chapter III, Section L.14 and the contextual modifier 59 dermatology guide. Check the current code-pair edit rather than extending one example to every destruction code.
Modifier Relationships to Review
| Modifier | Relationship |
|---|---|
| 25 | Significant, separately identifiable E/M work |
| 59 | Distinct procedural service when a more specific modifier does not better describe it |
| XE | Separate encounter |
| XS | Separate structure |
| XU | Unusual nonoverlapping service |
| 58 | Staged or related procedure in applicable circumstances; see the Mohs exception below |
Skin Biopsy With Mohs Surgery
Biopsy work integral to Mohs treatment of the same lesion is generally included. A separate diagnostic biopsy before proceeding to Mohs, or a biopsy on a different lesion, requires careful documentation and reporting review.
Keep the exception specific. CMS describes separate reporting for a suspected cancer biopsied for diagnosis before proceeding to Mohs. The record needs to establish the timing, diagnostic reason, and relationship to definitive treatment. Applicable modifiers and pathology reporting depend on the circumstances.
Document the lesion biopsied, the lesion treated with Mohs, the site of each, and the sequence of services. Do not separately report pathology that is integral to the same physician’s Mohs service.
See CMS Chapter III, Section F for the exception and consider Mohs surgery billing support when recurring claim issues involve these relationships.
Document Every Lesion and Procedure Clearly
A lesion-level record should connect the site, clinical concern, technique, and procedure. Include the number of lesions, relevant description or size, specimen identification, and closure or hemostasis when applicable.
Example: A Traceable Procedure Record
| Lesion | Location | Clinical Concern | Procedure |
|---|---|---|---|
| A | Left upper back | Irregular pigmented lesion | Tangential biopsy |
| B | Right forearm | Indurated papule | Punch biopsy |
| C | Forehead | Actinic keratosis | Cryotherapy |
Support the clinical indication and diagnosis selection with the actual record. Do not assume an unconfirmed pathology result or manufacture a diagnosis to obtain coverage. The medical necessity documentation article explains why procedure details and clinical rationale need to work together.
Biopsy and Pathology Are Different Services
The biopsy code represents tissue procurement. Pathology reporting concerns examination of the specimen and has its own rules, billing responsibilities, and units. Biopsy lesion counts and pathology specimen counts should not be treated as interchangeable.
Common Skin Biopsy Coding Mistakes
Unspecified Technique
Correction: Query an unclear note before selecting tangential, punch, or incisional coding.
Multiple Primary Codes
Correction: Apply the biopsy hierarchy and additional-lesion rules for mixed techniques.
Counting Specimen Containers
Correction: Establish how many separate lesions were biopsied.
Automatic Modifier Use
Correction: Confirm distinct work, lesion mapping, and the relevant edit before adding a modifier.
Biopsy/Removal Confusion
Correction: Use the documented intent and completed procedure to select the family.
Missing Anatomical Specificity
Correction: Check the exact structure and whether a site-specific code applies.
Skin Biopsy Claim Checklist
Before submission, confirm that the documentation and claim tell the same story.
- Each biopsied lesion has a distinct site and identifier.
- The technique supports the selected code family.
- The primary code and add-on combinations are appropriate.
- Units reflect additional lesions, not fragments or containers.
- Diagnosis selection and medical necessity match the record.
- Same-day procedures are mapped to the same or separate lesions.
- Modifiers are supported and the current edit permits their use.
- Site-specific, coverage, and payer requirements have been checked.
When these gaps recur, dermatology coding and documentation audits can help identify where the clinical-to-billing handoff needs attention.
Keep the references current. Check the applicable CPT year, current NCCI edits, Medicare Administrative Contractor policies, and commercial-payer instructions. An annual guide does not establish a new rule unless a specific change is verified.
Skin Biopsy Billing FAQs
What CPT codes are used for skin biopsies?
11102–11107 cover tangential, punch, and incisional skin biopsies, with primary and additional-lesion codes. Confirm whether a site-specific biopsy code better describes the procedure.
What is CPT 11102 used for?
A tangential biopsy of a single skin lesion for diagnostic evaluation, when the documented technique and requirements support it. Shave removal for removal intent uses different reporting rules.
How are biopsies using different techniques reported?
Report one primary skin biopsy code according to the applicable hierarchy, then appropriate technique-specific add-on codes for additional lesions. Do not report a separate primary code for every technique.
Does every same-day biopsy visit support modifier 25?
No. Significant, separately identifiable E/M work must extend beyond the usual biopsy-related work. New-patient status and the decision to biopsy alone do not establish this.
Can a skin biopsy be separately billed with Mohs surgery?
Integral biopsy work on the Mohs lesion is generally included. A separate diagnostic biopsy before proceeding to Mohs or a biopsy on another lesion requires documentation, modifier, NCCI, and payer review.
Does sending several containers mean several biopsies?
No. Biopsy reporting depends on separately biopsied lesions. Multiple containers or fragments from one lesion do not automatically create additional biopsy units; pathology has separate specimen-reporting rules.
Reference: 2026 Medicare NCCI Policy Manual, Chapter III. Code summaries are paraphrased reference descriptions; use the current CPT Professional codebook for complete descriptors and instructions. Medicare guidance should not be assumed to apply identically to every payer.
